"Im Rahmen des "Regionalen Strukturplan Gesundheit 2025" (RSG) soll in Kooperation mit dem Krankenhaus der Elisabethinen Graz das "Ordenskrankenhaus Graz-Mitte" entstehen."

During the past decade, Krankenhaus der Barmherzigen Brüder Graz conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder Graz" #1 sponsor was "ARCAGY/ GINECO GROUP" with 1 trials, followed by "Arcagy Research" with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored and "Medical University Innsbruck" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus der Barmherzigen Brüder Graz" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "AF Schimetta GMbH" with 1 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "Anticancer Fund, Belgium" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Krankenhaus der Barmherzigen Brüder Graz" are "Ovarian Cancer" (3 trials), "Anastomotic Leak Rectum" (1 trials), "Arthritis, Psoriatic" (1 trials), "Cervical Dystonia" (1 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Krankenhaus der Barmherzigen Brüder Graz" in a lesser frequency.

Most popular intervention types in "Krankenhaus der Barmherzigen Brüder Graz" are "Drug" (6 trials), "Device" (2 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Botulinum toxin type A" (1 trials), "Guselkumab" (1 trials), "IL-17i" (1 trials) and "Letrozole 2.5mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krankenhaus der Barmherzigen Brüder Graz" are 5 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Krankenhaus der Barmherzigen Brüder Graz". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Krankenhaus der Barmherzigen Brüder Graz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krankenhaus der Barmherzigen Brüder Graz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Krankenhaus der Barmherzigen Brüder Graz has several departments that took part in Clinical trials: "Barmherzige Brüder Linz - Innere Medizin" - 2 trials, "Krankenhaus der Barmherzigen Brüder/Abteilung für Neurologie" - 2 trials